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Macrophages and CD4-positive T lymphocytes are the major targets and producers of HIV-1. While the
molecular details underlying HIV replication in macrophages and T cells become better understood, it
remains unclear whether viruses produced by these target cells differ in their biological properties.
Recent reports suggest that HIV virions incorporate a large number of producer cell proteins and lipids
which have an effect on subsequent viral replication in newly infected cells. The identity and abundance
of these incorporated factors varies between different types of producer cells, suggesting that they may
inﬂuence the replication capacity and pathogenic activity of the virions produced by T cells and
macrophages.
& 2013 Elsevier Inc. All rights reserved.Background
Two types of immune cells, macrophages and CD4+ T lympho-
cytes, are the major targets of HIV-1 in the body. Although a number
of other cells, including monocytes, dendritic cells, CD8+ T lympho-
cytes, endothelial cells, hematopoetic stem cells, and astrocytes have
been reported to harbor HIV provirus (Lunardi-Iskandar et al., 1989;
Tsubota et al., 1989; De Maria et al., 1991; Langhoff et al., 1991;
Langhoff and Haseltine, 1992; Steffan et al., 1992; Moses et al., 1993;
Monte et al., 1992; Carter et al., 2010; Churchill et al., 2009), virus
replication in these cell types is inefﬁcient or abortive and is unlikely
to contribute to viral population in vivo. Early reports divided HIV-1
phenotype into macrophage-tropic and T cell-tropic, with an under-
lying idea that macrophages express CCR5, but not CXCR4, and are
therefore subject to infection by R5, but not X4 HIV-1 isolates,
whereas most CD4+ T cell populations express CXCR4 (only memory
T cells express CCR5) and are therefore sensitive to X4 HIV-1 isolates
(reviewed in Mosier (2000)). These ideas started to change when it
became clear that CXCR4 is expressed on macrophages (Zaitseva
et al., 1997; Yi et al., 1998; Verani et al., 1998), and that macrophage
tropism is determined not only at entry, but also at post-entry steps
of infection (Schmidtmayerova et al., 1998; Duncan and Sattentau,
2011). Furthermore, naturally transmitted HIV-1 viruses are almost
exclusively R5-tropic yet their primary targets are T cells and notll rights reserved.
y),
. Bukrinsky).macrophages (Keele et al., 2008). In fact, macrophage tropism of R5
viruses is most pronounced in a subpopulation of viruses found in
CNS, where they infect and replicate in microglial cells, whereas
some X4 and dual-tropic viruses in the periphery efﬁciently infect
macrophages via CXCR4 (Gorry and Ancuta, 2011). It becomes clear
now that genetically identical viruses can replicate in macrophages
and T cells, although the activity of distinct viral genes can differ
between host cell types due to the differing cell environment,
including the spectra of host proteins, regulation of host gene
expression, and size and organization of subcellular compartments.
As a result, viruses produced by macrophages and T cells can be
genetically identical, but they may incorporate different host cell
proteins. These proteins may not only favor infection of a particular
cell type, but may also determine the efﬁciency of viral replication
and, therefore, viral pathogenesis. The role in HIV replication of host
cell proteins that associate with the plasma membrane and are
incorporated into HIV-1 virions as part of the viral envelope has been
reviewed previously (Kolegraff et al., 2006). In this article, we will
update this information, but will pay most attention to proteins
incorporated from producer cell into the cores of nascent virions,
focusing on the proteins that vary amongst the primary producer
cells, T cells and macrophages.
Assembly pathways inﬂuence the spectrum of virion-
incorporated host-cell proteins
Incorporation of host cell proteins into nascent virions occurs
during virus assembly and budding. The spectrum of these proteins
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virions associate with during assembly, and on the abundance of
particular proteins in these compartments. The assembly process is
primarily driven by HIV-1 Gag (Ono, 2009; Accola et al., 2000) and
exploits the endosomal sorting complex required for transport
(ESCRT) pathway for the cellular membrane remodeling and budding
of the virions ((Demirov et al., 2002; Garrus et al., 2001; von
Schwedler et al., 2003; Martin-Serrano et al., 2003; Martin-Serrano
and Neil, 2011; Weiss and Gottlinger, 2011), for a recent review see
Meng and Lever (2013)). Whereas analysis of the virion assembly in
the T lymphocytes and model epithelial cells and ﬁbroblasts indi-
cated plasma membrane as a primary cellular site of HIV particle
assembly and budding (Perez-Caballero et al., 2004; Ono and Freed,
2004; Finzi et al., 2007), the electron microscopy and immunoﬂuore-
sent microscopic studies of infected macrophages revealed accumu-
lation of virions within intracellular compartments—the late
endosomes or multivesicular bodies (MVB) (Pelchen-Matthews
et al., 2003; Raposo et al., 2002; Jouve et al., 2007). In fact, the
typical endosomal markers CD63, CD9, CD81 and MHC class II, as
well as lysosome-associated membrane protein-1 (Lamp1), were
found to co-localize with HIV-1 particles in infected macrophages
(Pelchen-Matthews et al., 2003; Nguyen et al., 2003; Raposo et al.,
2002; Welsch et al., 2007). These data suggested that in macrophages
Gag speciﬁcally targets the endosomal membranes resulting in
particle release into the lumen of late endosomes. However, later
study showed that the endosomal localization of the Gag molecules
and HIV-1 virions in macrophages could be a result of their
secondary internalization from the plasma membrane (Jouvenet
et al., 2006). Recent studies of HIV-1 infected macrophages revealed
an extensive tubular network and large internally sequestered
plasma membrane domains that carry late endosomal markers but
are connected to the cell surface. These structures contained HIV-1
virions that were released into the extracellular space (Welsch et al.,
2007; Deneka et al., 2007; Gousset et al., 2008; Bennett et al., 2009).
These ﬁndings explain the contradiction between the accumulation
of HIV-1 particles in intracellular membranous compartments and
the primary targeting of HIV-1 particle assembly to the plasma
membrane. The consensus now is that the virus particle assembly
pathway is similar in both major types of natural HIV-1 target cells,
CD4+ T lymphocytes and macrophages, and virus exploits the same
key host proteins and protein ensembles for the assembly and
release. Nevertheless, differences in the gene expression spectra
between the T cells and macrophages, as well as host proteins
associated with HIV-1 assembly and budding, can impact protein
composition of the progeny virions.
The effect of differences between producer cell types on host
cell proteins incorporated into progeny virions is illustrated by
comparison of recent proteomic data (Chertova et al., 2006;
Stephenson et al., 2010; Santos et al., 2012; Bregnard et al.,
2013). While a large number from over a 1000 identiﬁed proteins
overlap between these studies, there were also differences, most
likely due to different producer cells used to prepare virions. Our
analysis of the cores of HIV-1 virions produced from T lympho-
cytes (Sup-T1 cells) and macrophage model cells (PMA and
vitamin D3 activated THP-1 cells) revealed two-fold higher
amount of the vesicular trafﬁcking-associated proteins in the
macrophage-derived HIV-1 cores than in the cores of virions
produced from T cells (Santos et al., 2012). This is consistent with
the mode of virion assembly in macrophages, as assembly in
intracellular compartments is expected to lead to more vesicular-
trafﬁcking proteins being incorporated. The cytoplasm of macro-
phage model cells also contained higher abundance of actin and β
tubulin than Sup-T1 cells. Our data also conﬁrmed that the amount
of β tubulin in the viral cores correlated with the concentration of
this protein in the producer cells, suggesting passive capturing, but
not speciﬁc incorporation (Santos et al., 2012). Therefore, itappears that most cytoskeletal proteins are passively incorporated
into the nascent virions. Identifying which ones actually exert an
effect on the viral life cycle and alter the replication of progeny
virions remains a challenging task.
A number of host cell factors interact speciﬁcally with assem-
bling HIV particles. In this case, incorporation into the virion is less
dependent on the abundance of these proteins in one or the other
type of producer cell. An example of such proteins is cyclophilin A,
which is packaged in association with the viral capsid into the
virions produced by both primary lymphocytes and macrophages
in similar amounts (Saini and Potash, 2006). Virion-incorporated
CypA appears to provide only a small advantage to HIV replication
(Pushkarsky et al., 2001), which is regulated mostly by target cell
cyclophilin (Sokolskaja et al., 2004; Schaller et al., 2011). However,
it is also possible that even host cell factors speciﬁcally interacting
with assembling HIV particles must meet a certain concentration
threshold to be incorporated in sufﬁcient amounts to have
physiological effect, thus contributing to differences between
progeny virions from different producer cells.Virion incorporation of Host cell proteins from HIV-1 infected
T lymphocytes and macrophages and their role in the next
round of infection
While many virion-incorporated host cell proteins do not
contribute to host cell tropism of the progeny virus, some
producer cell proteins may be involved in the post-entry stages
of HIV-1 infection. As we saw in the previous section, diverse
expression proﬁles and different localization of virion assembly
units in T lymphocytes and in macrophages determine differences
in the spectra of virion-incorporated proteins.
Incorporation of some host cell proteins, such as staufen 1, RNA
helicase A (RHA), INI1/hSNF5 and SAP18, a component of the
Sin3a-HDAC1 complex, which are involved in the virion assembly,
maturation or in the next round of infection, has been demon-
strated only in virus or virus-like particles produced by HEK 293T
or HeLa cells (Chatel-Chaix et al., 2008, 2007; Roy et al., 2006;
Bolinger et al., 2010; Xing et al., 2011; Yung et al., 2004; Sorin et al.,
2009). However, for some cellular factors playing an important
role in HIV-1 replication, the differences in incorporation were
shown for physiologically relevant cell types, and we will describe
these factors below.Annexin II
Enrichment of myeloid cells with some cellular proteins that
are not present or are low-abundant in lymphocytes determines
the spectrum of cellular proteins found in HIV-1 virions derived
from macrophages. It has been shown earlier that a calcium and
phospholipid-binding protein annexin II involved in regulation of
exocytosis and abundant in macrophages, facilitates early steps of
infection in macrophages, but not in T cells (Ma et al., 2004; Wahl
et al., 2006). This cytoskeleton- and membrane-associated protein
directly binds to Pr55Gag, and inhibition of this interaction during
the assembly stage in macrophages decreases infectivity of pro-
geny virions. This interaction is macrophage-speciﬁc as PBLs do
not express annexin II. It was demonstrated that annexin II affects
replication in macrophages by organizing the specialized lipid
rafts that are optimal for Gag assembly on endosomal membranes
(Ryzhova et al., 2006). It should be noted here, that later studies
reported that depletion of annexin II does not affect the produc-
tion of virions in macrophages, but regulates infectivity of pro-
duced virions (Rai et al., 2010). Taken together, these data suggest
that annexin II is speciﬁcally incorporated into virions produced by
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but is dispensable for replication in other cell types.
Nuclear uracil DNA Glycolase (UNG2)
UNG2 comes into virions in association with Vpr (Willetts et al.,
1999; Chen et al., 2004) and integrase (Priet et al., 2003). Earlier
studies showed a critical role of UNG2 in a decrease of virus
mutation frequencies in target cells, but primarily in macrophages,
where UNG2-mediated suppression of mutation rate was almost
ﬁvefold higher than in T cells (Chen et al., 2004). Later reports
demonstrated that only the R5 virions produced from UNG2-
depleted PBMCs and MDM exhibited low level of late cDNA
synthesis, whereas the X4 isolates did not display dependence on
the endogenous UNG2 during infection of both PBMCs and macro-
phages, suggesting that the UNG2 activity in reverse-transcription
complexes may depend on the activation of signaling pathways in
response to HIV-1 envelope-co-receptor binding (Jones et al., 2010).
However, recently published data demonstrated that enforced
recruitment of UNG2 from virus-producing cells into the virions
similarly inﬂuenced infectivity of X4 and R5 HIV-1 strains in both
transformed cell lines (HEK 293T, HeLa-CD4) and primary macro-
phages (Guenzel et al., 2012). Moreover, the authors showed that
the decrease of a mutation rate and more efﬁcient reverse tran-
scription in the viruses with incorporated nuclear form of UNG2
were independent of the enzymatic activity of UNG2 (speciﬁc
removal of the uracil residues from DNA). The possible mechanism
of positive effect of UNG2 lies in its interactionwith the p32 subunit
of the replication protein A (RPA) complex, which is functional in
both T cells and macrophages (Guenzel et al., 2012). Therefore, it
appears that virion-incorporated UNG2 is required for HIV infectiv-
ity in both target cell types.
ERK2
Studies of another virion-associated host cell protein, ERK2,
demonstrated its involvement in phosphorylation of inner nuclear
lamina protein emerin (EMD) during viral replication in non-
dividing cells (Jacque et al., 1998; Bukong et al., 2010), suggesting
that ERK2 incorporation may facilitate infection of terminally
differentiated macrophages and resting T cells. It should be noted
that conﬂicting data exist regarding the role of Barrier to Auto-
integration factor (BAF) and other nuclear lamina proteins in HIV
infection of non-dividing cells, with some groups stating their
requirement, while others ﬁnding these proteins dispensable
(Bukong et al., 2010; Bergamaschi and Pancino, 2010; Mulky
et al., 2008). Most likely, these contradictory data are due to
different growth conditions and the proliferation status of the
cells. Therefore, the effect of ERK2 expression in the producer cell
on infectivity of progeny virions and possible phosphorylation
targets in the newly infected cell remain to be determined.
Chaperones
Such cellular proteins as clathrin, thioltransferase, and heat
shock protein 70 (HSP70), that are probably involved in organiza-
tion of virion interior, regulation of viral protease activity, and
correct folding of the Pol products, were found to be abundant in
the highly infectious viral particles produced from infected T cell
lines (CEMX174 and MT2, H9, Jurkat), whereas virions harvested
from transfected HEK 293T cells displayed a lower level of
packaging of these factors (Zhang et al., 2011; Davis et al., 1997;
Gurer et al., 2002). Our recent proteomic analysis revealed a higher
diversity of the host proteins, including chaperones, in the cores of
T cell-derived virions, than in the core structures of viruses
produced by the macrophage model cells (PMA and vitamin D3activated THP-1) (Santos et al., 2012). Moreover, within the group
of proteins detected in the cores of virions from all cells types, the
incorporation rate of some factors involved in reverse transcrip-
tion (RHA (Roy et al., 2006; Xing et al., 2011)) and cDNA nuclear
import and circularization (Ku70/Ku80 (Li et al., 2001; Jeanson
et al., 2002)) was higher in the viral cores from T cells than in the
cores from both macrophage and monocyte model cells, and did
not correlate with the abundance of these proteins in virus
producing cells, suggesting their speciﬁc incorporation into the
viral cores produced in T cells. These data suggest that the higher
abundance and variety of chaperones and other host cell factors in
the cores of T cell-derived viruses, as well as earlier observed
cholesterol enrichment of the viral envelope (Cui et al., 2012),
together facilitate higher infectivity of the T lymphocyte-derived
viruses relative to viruses produced by macrophages.
Membrane proteins
Several membrane proteins (HLAs, CD80, CD86 and ICAM-1)
have been shown to increase HIV-1 infectivity via enhanced
attachment to the target cell (Cosma et al., 1999; Cantin et al.,
1997b, 1997a; Fortin et al., 1997, reviewed in Cantin et al., 2005),
suggesting that differential incorporation of these proteins may
affect HIV-1 infectivity. Of interest, one recent study of Human
Discs Large (Dlg1), a scaffold protein located beneath the plasma
membrane and involved in the assembly of multiprotein com-
plexes, showed that in T cells Dlg1 binds HIV-1 Gag, and depleting
Dlg1 leads to progeny virions with increased infectivity, suppo-
sedly due to re-localization of Gag to membrane structures
enriched in tetraspanins CD63 and CD82 (Perugi et al., 2009).
However, tetraspanin-enriched microdomains of the plasma
membrane are normal sites of HIV-1 assembly and budding
(Thali, 2009), and another study demonstrated that when CD63
was excluded from HIV-1 producing T cells after T cell activation,
infectivity of released virions was increased (Sato et al., 2008),
suggesting an inhibitory effect of this protein on HIV infectivity.
Consistent with this notion, CD63 was shown to inhibit viral entry
via HIV-1 Env, and this mechanism of inhibition was demonstrated
across tetraspanins (CD9, CD81, CD82, CD231) (Sato et al., 2008;
Krementsov et al., 2009; Weng et al., 2009, reviewed in Thali,
2011). Of particular interest is that this inhibition appears to be
strain-speciﬁc, occurring only in T-tropic viral strains of NL4-3 and
IIIB, and not in the M-tropic strain of JR-FL (Sato et al., 2008). These
data allowed speculation that M-tropic strains overcame this
tetraspanin inhibition, possibly due to virions' unique assembly
location within macrophages. Further studies into tetraspanins'
mechanism of action will probably determine precisely how these
membrane proteins affect HIV infectivity, from potential virion
beneﬁts of properly assembling in tetraspanin rich microdomains
to the post-attachment inhibitory mechanisms of tetraspanins
seen in target cells.
Helicases
Most recently, the role of RNA helicases in HIV-1 infection has
come under intense investigation, with the revelation of a multi-
tude of helicases involved in the various stages of the HIV-1 life
cycle. The best characterized functions of RNA helicases are at the
stages of RNA processing and gene expression, with DDX3 and
DDX1 facilitating REV export of viral RNA and UPF1 up-regulating
HIV-1 expression (Yedavalli et al., 2004; Liu et al., 2011; Ajamian
et al., 2008). Some helicases down-regulate HIV-1 expression (e.g.
Dicer, RIG-1, MOV10, (Christensen et al., 2007; Burdick et al., 2010;
Arjan-Odedra et al., 2012, reviewed in Lorgeoux et al., 2012). The
endogenous expression of any one or combination of these
helicases would modulate the overall virion production in the
S. Iordanskiy et al. / Virology 443 (2013) 208–213 211producer cell and, probably, affect the next round of infection if
these functionally active proteins are packaged into the virions.
Given that their potential activity within the target cell is aimed at
viral RNA or cDNA located within the same nucleoprotein com-
plex, the amount of helicase molecules required to exert an effect
on viral reverse transcription or integration does not need to be
very large. Thus, cell-type differences in the expression of these
RNA helicases and their incorporation into the virions should be
looked into further for their possible roles in establishing latent or
productive infections.
Mentioned brieﬂy above, RHA plays a role in facilitating more
efﬁcient reverse transcription (Roy et al., 2006; Xing et al., 2011).
Although this effect was established only within an artiﬁcial model, it
would still be interesting to understand it from a mechanistic point
of view. Another RNA helicase, MOV10, has sparked some interest
because of its restrictive capabilities towards HIV-1 infectionwithin T
cells. It has been shown that, similar to APOBEC3G, a well-
characterized HIV-1 restriction factor that hypermutates HIV-1 cDNA
during reverse transcription and is incorporated into the virions
through combined action of RNA binding and interaction with NC
(reviewed in Malim and Bieniasz, 2012), MOV-10 is incorporated into
HIV-1 virions via interaction with Gag and NC (Burdick et al., 2010).
However, how this RNA helicase restricts HIV-1 infection at the post-
entry steps remains to be revealed.
We detected a signiﬁcantly higher level of incorporation of
subunits 3 and 5 of another important cellular replicative helicase,,
the hexameric MCM2-7 complex, into the cores of T cell-derived
virions, relative to cores of virions produced from macrophage or
monocyte model cells (Santos et al., 2012). Interestingly, knock-
down of MCM3 and 5 monomers in virus-producing cells resulted
in generation of MCM-deﬁcient viral particles which displayed
reduced level of reverse transcription in Jurkat and Sup-T1 cells
(unpublished data), suggesting that this cellular factor incorpo-
rated into the viral cores can be involved in control of viral reverse
transcription.Hijacking of cholesterol by HIV-1 virions from virus-producing
T cells and macrophages determines differences in virus
infectivity
Our group previously demonstrated that HIV-1 infection,
through the effect of Nef protein, inhibits ABCA1 and cholesterolTable 1
Virion-associated host factors.
Factor Role in viral replication Enriched in (p
cell type)
Annexin II Assists viral assembly Macrophages
Cholesterola Improves fusogenic capacity Macrophages
Clathrin Facilitates morphogenesis T cells
Dlg1 Restricts infectivity T cells
ERK2 Stimulates infectivity b
HSP70 Stimulates reverse transcription T cells
Ku70/Ku80 Stimulates cDNA nuclear import and circularization T cells
MCM helicase Stimulates RT T cells
Mov10 Unknown, may inhibit RT T cells
RHA Stimulates RT T cells
Thioltransferase Regulates protease activity T cells
UNG2 Reduces viral mutation rate, stimulates RT b
a Regulated by differential expression of the host cellular protein ABCA1 within pro
b Similar expression in T cells and macrophages.efﬂux in target cells to ensure delivery of cholesterol to nascent
virions during assembly (Mujawar et al., 2006). We also showed
that pharmacological stimulation of expression of ABCA1, the main
cellular cholesterol transporter responsible for the efﬂux of choles-
terol and phospholipids to lipid-poor apolipoproteins, inhibits HIV-
1 infectivity by depleting viral cholesterol (Morrow et al., 2010). An
intriguing consequence of these ﬁndings is that HIV infectivity may
be inﬂuenced by the natural level of ABCA1 expression in infected
cells. When ABCA1 levels are compared between monocyte derived
macrophages (MDM) and CD4+ T lymphocytes, signiﬁcant differ-
ences can be observed. Although ABCA1 abundance in both cell
types can be increased by an agonist of nuclear receptor LXR, which
regulates ABCA1 transcription, there is a dramatic difference in the
level of ABCA1 expression. Unstimulated peripheral blood leuko-
cytes (PBL) have undetectable levels of ABCA1, whereas ABCA1 in
MDM can be easily detected by Western blot, even without
stimulation of LXR (Cui et al., 2012). Infectivity of HIV-1 produced
by these cells correlated perfectly with the level of ABCA1 expres-
sion: when measured in the indicator cell line TZM-bl, infectivity of
the virus produced by “high ABCA1” cell type, MDM, was about 70%
lower than of the virus produced by “low ABCA1” cell type, PBL (Cui
et al., 2012). Importantly, knock down of ABCA1 in MDM by siRNA
brought infectivity of produced virus close to infectivity of the virus
produced by PBL. Thus, differences in ABCA1 expression in host
cells have a signiﬁcant effect on infectivity of produced HIV virions,
likely through the effect on viral cholesterol and fusogenic capacity
of the virus (Morrow et al., 2010). Higher infectivity of T cell-
produced virus underscores the central role of these cells as HIV-1
reservoir.Conclusions
Incomplete and occasionally controversial data about functions of
the host proteins in HIV-1 life cycle do not allow clear conclusions
regarding the role of virion-incorporated cellular proteins in viral
infectivity, cell speciﬁcity and efﬁciency of subsequent replication.
Nevertheless, available information suggests that HIV-1 particles
assembled in T cells are enriched in both the cholesterol and producer
cell proteins relative to virions assembled in macrophages. This may
contribute to higher infectivity of T cell-produced virions due to
increased fusion capacity and higher efﬁciency of cDNA synthesis, as
well as optimal PIC organization for integration. Recruitment ofroducer Critical for replication
in (target cell type)
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infection of cells of the same type. Indeed, within unique cellular
factors identiﬁed earlier in the HIV-1 particles from monocyte-derived
macrophages and macrophage cell lines, at least ﬁve proteins, GTP-
binding nuclear protein Ran, importins α2, β1, β2 and transportin-SR2,
were involved in the nuclear import machinery (Chertova et al., 2006;
Santos et al., 2012), which is particularly critical for HIV infection of
non-dividing cells. Thus, the capacity of virus to infect the cells of a
certain type is likely dependent not only on the genotype of an HIV
strain, but also on the subset of host components hijacked by the
virion from the producer cell (Table 1), representing a non-genetic
mechanism of determination of the virus tropism.Author's contributions
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